Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges - Top-Institutions - MDSpire

Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges

  • By

  • Ningping Xiao

  • Chao Chen

  • Xiuyu Yang

  • Jiajia Hao

  • Mian Xie

  • Jiangtao Wang

  • Jiayu Xiang

  • Chang Liu

  • Xiulin Jiang

  • Siwei Huang

  • Zijia Wang

  • Yi Jin

  • July 3, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #3

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, New York

    Key Differentiators

    • Oncology
    • Immunotherapy

  • #4

    Brooke Army Medical Center
    Brooke Army Medical Center

    Fort Sam Houston, Texas

    Key Differentiators

    • Oncology
    • Immunotherapy

Original Source(s)

Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges

  • by Ningping Xiao, Chao Chen, Xiuyu Yang, Jiajia Hao, Mian Xie, Jiangtao Wang, Jiayu Xiang, Chang Liu, Xiulin Jiang, Siwei Huang, Zijia Wang, Yi Jin

  • July 3, 2026

Related Content

Transfer RNA expression, modification, and derived small RNAs in cancer biology and clinical potential

Detection of cancer recurrence from Thai-English electronic medical records using sentence embeddings

Crucial role of IL-6, IL-8, IL-11 and leptin in tumor microenvironment in a group of patients with GEP-NETs- crosstalk between inflammation and cancer